Basis Of Presentation

9 Months Ended

Sep. 30, 2012

Basis Of Presentation [Abstract]

Basis Of Presentation

Note 1: Basis Of Presentation

The consolidated financial statements include the financial statements of Hemispherx Biopharma, Inc. and its wholly-owned subsidiaries. The Company has three domestic subsidiaries: BioPro Corp., BioAegean Corp. and Core Biotech Corp., all of which are incorporated in Delaware and are dormant. The Company's foreign subsidiary, Hemispherx Biopharma Europe N.V./S.A., established in Belgium in 1998, has minimal activity. All significant intercompany balances and transactions have been eliminated in consolidation.

      In the opinion of Management, all adjustments necessary for a fair presentation of such consolidated financial statements have been included.  Such adjustments consist of normal recurring items.  Interim results are not necessarily indicative of results for a full year. 

      The interim consolidated financial statements and notes thereto are presented as permitted by the Securities and Exchange Commission ("SEC"), and do not contain certain information which will be included in the Company's annual consolidated financial statements and notes thereto. 

      These consolidated financial statements should be read in conjunction with the Company's consolidated financial statements for the year ended December 31, 2011, contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2011.